BIOVECTRA

biovectra-logo

BioVectra manufactures ingredients for global pharmaceutical and biotechnology clients offering therapeutics used in the treatment of cancer, kidney disease, cardio-vascular disease, multiple sclerosis, and many other serious diseases. With over 40 years experience, the company is proficient in synthetic organic chemistry, fermentation of chemical and biologic molecules, downstream processing, MPEG production, and conjugation chemistry. BioVectra was founded on 1970 and is based in Charlottetown, Canada.

#SimilarOrganizations #People #Financial #Website #More

BIOVECTRA

Social Links:

Industry:
Biotechnology Health Care Manufacturing Therapeutics

Founded:
1970-01-01

Address:
Charlottetown, Prince Edward Island, Canada

Country:
Canada

Website Url:
http://www.biovectra.com

Total Employee:
251+

Status:
Active

Contact:
866.883.2872

Email Addresses:
[email protected]

Total Funding:
77.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

anika-therapeutics-logo

Anika Therapeutics

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

applikon-biotechnology-logo

Applikon Biotechnology

A world leader in developing and supplying advanced bioreactor systems from laboratory scale to production scale.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

biomeasure-logo

Biomeasure

Biomeasure is a developer of non-invasive health assesment tools.

celltrion-logo

Celltrion

Celltrion engaged in the research, development, and manufacture of therapeutic proteins.

chemo-iberica-logo

Chemo Iberica

Chemo Iberica, S.A. manufactures and distributes generic medicines. It offers pharmaceuticals; agrochemicals, including insecticides,

cytovance-biologics-logo

Cytovance Biologics

Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.

encube-ethicals-logo

Encube Ethicals

Encube Ethicals a contract development and manufacturing organization, specializes in topical semisolid formulations.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

greatbatch-logo

Greatbatch

Greatbatch, Inc. (Greatbatch) is developer and manufacturer of components for implantable medical devices (IMDs) and Electrochem batteries

kindeva-drug-delivery-logo

Kindeva Drug Delivery

Kindeva Drug Delivery is a global contract development and manufacturing organization (CDMO) in the pharmaceutical industry.

microdermis-logo

Microdermis

Microdermis manufactures and markets skin care products for skin repair and protection, antimicrobial, and dental skin care.

nova-biomedical-logo

Nova Biomedical

Nova Biomedical provides advanced technology blood testing analyzers, based on electrochemical and optical measuring techniques.

opk-biotech-logo

OPK Biotech

OPK Biotech develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to

osteobiologics-logo

OsteoBiologics

OsteoBiologics engages in the development and manufacture of bioabsorbable polymeric scaffolds, films, and related instrumentations.

simcere-pharma-logo

Simcere Pharma

Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.

solid-state-cooling-systems-logo

Solid State Cooling Systems

Systems engineers thermal management solutions for laser, laboratory, medical and biopharmaceutical and the semiconductor industry.

bio-techne-logo

Bio-Techne

Bio-Techne is a supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.

trio-healthcare-logo

Trio Healthcare

Trio Healthcare International manufactures and markets products for ostomy, wounds, and other continence issues.

viamed-logo

Viamed

Viamed focuses on the development, manufacture and distribution of innovative medical products.

vibalogics-logo

Vibalogics

Vibalogics is a contract development and manufacturing organization focused on complex live biological products.

yposkesi-logo

YposKesi

Yposkesi is a European Contract Development & Manufacturing Organization (CDMO) for Gene and Cell Therapy - Lentivirus & AAV viral vectors.


Current Advisors List

scott-zhu_image

Scott Zhu Board of Directors @ BioVectra
Board_member
2019-01-01

Current Employees Featured

heather-delage_image

Heather Delage
Heather Delage Chief Commercial Officer @ BioVectra
Chief Commercial Officer
2020-09-01

scott-doncaster_image

Scott Doncaster
Scott Doncaster Vice President, Manufacturing Technologies and Engineering @ BioVectra
Vice President, Manufacturing Technologies and Engineering
1995-11-01

oliver-technow_image

Oliver Technow
Oliver Technow Chief Executive Officer @ BioVectra
Chief Executive Officer
2019-11-01

regis-duffy_image

Regis Duffy
Regis Duffy Founder @ BioVectra
Founder

marc-sauer_image

Marc Sauer
Marc Sauer Chief Science Officer @ BioVectra
Chief Science Officer
2022-04-01

david-long_image

David Long
David Long Chief Financial Officer @ BioVectra
Chief Financial Officer
2020-11-01

ted-dolan_image

Ted Dolan
Ted Dolan Chief Operating Officer @ BioVectra
Chief Operating Officer

Founder


regis-duffy_image

Regis Duffy

Investors List

government-of-canada_image

Government of Canada

Government of Canada investment in Grant - BioVectra

strategic-innovation-fund-sif_image

Strategic Innovation Fund (SIF)

Strategic Innovation Fund (SIF) investment in Grant - BioVectra

Official Site Inspections

http://www.biovectra.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.12 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioVectra"

Biologics, API & Drug Development CDMO | BIOVECTRA

Jan 26, 2023 BIOVECTRA is a North American CDMO specializing in clinical-to-commercial scale production capabilities for: Our teams, backed by 50+ years of experience and a proven track record of excellence, optimize, adapt, and โ€ฆSee details»

Agilent Technologies to Acquire BIOVECTRA Inc., Creating New ...

Jul 22, 2024 About BIOVECTRA BIOVECTRA (www.biovectra.com) is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that โ€ฆSee details»

BioVectra Inc. - BioTalent Canada

BioVectra is a Contract Development and Manufacturing Organization (CDMO) that serves global pharmaceutical and biotech companies with full-service cGMP outsourcing solutions for โ€ฆSee details»

Agilent Completes Acquisition of BIOVECTRA

Sep 20, 2024 Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and โ€ฆSee details»

BioVectra - Crunchbase Company Profile & Funding

BioVectra offers contract development and manufacturing capacity for intermediates and active pharmaceutical ingredients.See details»

Agilent to Acquire North American CDMO BIOVECTRA

Jul 22, 2024 BIOVECTRA (www.biovectra.com) is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to โ€ฆSee details»

BIOVECTRA - LinkedIn

BIOVECTRA | 16,943 followers on LinkedIn. A global, full-service CDMO specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, & bioreagents. | Expertise in both microbial ...See details»

Agilent Completes Acquisition of BIOVECTRA - Morningstar

Sep 20, 2024 Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and โ€ฆSee details»

BioVectra Company Profile - Office Locations, Competitors, โ€ฆ

BioVectra is a biotech and pharmaceutical contract development and manufacturing organization (CDMO). It provides project support services such as rapid process development and โ€ฆSee details»

BioVectra Company Profile 2024: Valuation, Investors, Acquisition ...

Information on acquisition, funding, investors, and executives for BioVectra. Use the PitchBook Platform to explore the full profile.See details»

BioVectra - Company Profile - Tracxn

3 days ago Biovectra is a generic manufacturer and CDMO offering its services for the development of treatments targeting cancer, kidney and cardiovascular disease, multiple โ€ฆSee details»

Agilent to Acquire North American CDMO BIOVECTRA

Jul 22, 2024 Expands Agilentโ€™s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has โ€ฆSee details»

BIOVECTRA Information - RocketReach

BIOVECTRA is a Biotechnology, Business Services General, and GMP Fermentation company located in Charlottetown, Prince Edward Island with $102.5 million in revenue and 571 โ€ฆSee details»

Our Mission, Vision & Values - BIOVECTRA

Mission: We develop and manufacture quality products, creating value that exceeds expectations. At our core we solve complex therapeutic challenges together with our partners. Vision: โ€ฆSee details»

BIOVECTRA Company Overview, Contact Details & Competitors

Mar 3, 2019 Learn more about BIOVECTRA's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

BIOVECTRA - Technology Networks

BIOVECTRA BIOVECTRA is a North American contract development and manufacturing organization (CDMO) specializing in clinical-to-commercial scale production capabilities for โ€ฆSee details»

News - BIOVECTRA

Sep 20, 2024 SANTA CLARA, California, September 20, 2024 โ€“ Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a โ€ฆSee details»

Resources - BIOVECTRA

BIOVECTRA offers a number of resources to help keep you up to date on industry trends and activities. Meet with us at events, follow us on LinkedIn, and explore the following resources โ€ฆSee details»

BIOVECTRA mRNA Vaccine and Biomanufacturing Facility โ€ฆ

Feb 13, 2022 BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics โ€“ โ€ฆSee details»

linkstock.net © 2022. All rights reserved